Literature DB >> 26490187

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

Ichiro Fukumoto1,2, Naoko Kikkawa2, Ryosuke Matsushita3, Mayuko Kato1, Akira Kurozumi1, Rika Nishikawa1, Yusuke Goto1, Keiichi Koshizuka1,2, Toyoyuki Hanazawa2, Hideki Enokida3, Masayuki Nakagawa3, Yoshitaka Okamoto2, Naohiko Seki1.   

Abstract

In spite of considerable advances in multimodality therapy, including surgery, radiotherapy and chemotherapy, the overall survival rate for patients with head and neck squamous cell carcinoma (HNSCC) is very poor (only 15-45%). Understanding the molecular mechanisms of metastatic pathways underlying HNSCC using currently available genomic approaches might improve therapies for and prevention of the disease. Our previous studies showed that three tumor-suppressive microRNAs (miRNAs), miR-26a/b, miR-29a/b/c and miR-218, significantly inhibited cancer cell migration and invasion. Therefore, we hypothesized that these miRNAs-regulated target genes deeply contributed to cancer metastasis. These tumor-suppressive miRNAs directly regulate LOXL2 expression in HNSCC cells by using in silico analysis and luciferase reporter assays. Overexpressed LOXL2 was confirmed in HNSCC clinical specimens, and silencing of LOXL2 inhibited cancer cell migration and invasion in HNSCC cell lines. Our present data showed that tumor-suppressive miRNAs regulation of LOXL2 will provide new insights into the novel molecular mechanisms of HNSCC metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26490187     DOI: 10.1038/jhg.2015.120

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  48 in total

1.  Lysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma.

Authors:  Yin-Hua Shih; Kuo-Wei Chang; Michael Yuanchien Chen; Cheng-Chia Yu; Dan-Jae Lin; Shih-Min Hsia; Heng-Li Huang; Tzong-Ming Shieh
Journal:  Head Neck       Date:  2012-02-24       Impact factor: 3.147

2.  Activation of the NOTCH pathway in head and neck cancer.

Authors:  Wenyue Sun; Daria A Gaykalova; Michael F Ochs; Elizabeth Mambo; Demetri Arnaoutakis; Yan Liu; Myriam Loyo; Nishant Agrawal; Jason Howard; Ryan Li; Sun Ahn; Elana Fertig; David Sidransky; Jeffery Houghton; Kalyan Buddavarapu; Tiffany Sanford; Ashish Choudhary; Will Darden; Alex Adai; Gary Latham; Justin Bishop; Rajni Sharma; William H Westra; Patrick Hennessey; Christine H Chung; Joseph A Califano
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

Review 3.  MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.

Authors:  Ying-fei Lu; Li Zhang; Mary Miu Yee Waye; Wei-ming Fu; Jin-fang Zhang
Journal:  Exp Cell Res       Date:  2015-04-07       Impact factor: 3.905

Review 4.  Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor.

Authors:  Soo-Hyun Kim; Jeremy Turnbull; Scott Guimond
Journal:  J Endocrinol       Date:  2011-02-09       Impact factor: 4.286

Review 5.  Diverse roles of miR-29 in cancer (review).

Authors:  Hesong Jiang; Guang Zhang; Jun-Hua Wu; Chun-Ping Jiang
Journal:  Oncol Rep       Date:  2014-02-20       Impact factor: 3.906

6.  Protein O-fucosyltransferase 1: a potential diagnostic marker and therapeutic target for human oral cancer.

Authors:  Satoshi Yokota; Katsunori Ogawara; Ryota Kimura; Fumie Shimizu; Takao Baba; Yasuyuki Minakawa; Morihiro Higo; Atsushi Kasamatsu; Yosuke Endo-Sakamoto; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  Int J Oncol       Date:  2013-09-23       Impact factor: 5.650

Review 7.  MicroRNAs--micro in size but macro in function.

Authors:  Sunit K Singh; Manika Pal Bhadra; Hermann J Girschick; Utpal Bhadra
Journal:  FEBS J       Date:  2008-08-27       Impact factor: 5.542

8.  Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.

Authors:  Petra Barros dos Santos; Juliana S Zanetti; Alfredo Ribeiro-Silva; Eduardo I C Beltrão
Journal:  Diagn Pathol       Date:  2012-08-16       Impact factor: 2.644

Review 9.  MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas.

Authors:  Dan Chen; Robert J Cabay; Yi Jin; Anxun Wang; Yang Lu; Muzaffar Shah-Khan; Xiaofeng Zhou
Journal:  J Oral Maxillofac Res       Date:  2013-04-01

Review 10.  Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.

Authors:  Antonio Díaz-López; Gema Moreno-Bueno; Amparo Cano
Journal:  Cancer Manag Res       Date:  2014-04-25       Impact factor: 3.989

View more
  22 in total

1.  Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Ryosuke Matsushita; Hiroko Mataki; Keiko Mizuno; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-05-12       Impact factor: 3.172

2.  Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.

Authors:  Mayuko Kato; Akira Kurozumi; Yusuke Goto; Ryosuke Matsushita; Atsushi Okato; Rika Nishikawa; Ichiro Fukumoto; Keiichi Koshizuka; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-06-09       Impact factor: 3.172

Review 3.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

4.  Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.

Authors:  Kazuto Kamikawaji; Naohiko Seki; Masaki Watanabe; Hiroko Mataki; Tomohiro Kumamoto; Koichiro Takagi; Keiko Mizuno; Hiromasa Inoue
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

Review 5.  Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.

Authors:  Philip C Trackman
Journal:  Expert Opin Ther Targets       Date:  2016-03-03       Impact factor: 6.902

6.  Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.

Authors:  Tomohiro Kumamoto; Naohiko Seki; Hiroko Mataki; Keiko Mizuno; Kazuto Kamikawaji; Takuya Samukawa; Keiichi Koshizuka; Yusuke Goto; Hiromasa Inoue
Journal:  Int J Oncol       Date:  2016-09-13       Impact factor: 5.650

7.  Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Naoko Kikkawa; Toyoyuki Hanazawa; Yasutaka Yamada; Atsushi Okato; Takayuki Arai; Koji Katada; Yoshitaka Okamoto; Naohiko Seki
Journal:  Oncotarget       Date:  2017-12-11

8.  Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Naoko Kikkawa; Takayuki Arai; Atsushi Okato; Akira Kurozumi; Mayuko Kato; Koji Katada; Yoshitaka Okamoto; Naohiko Seki
Journal:  Cancer Sci       Date:  2017-07-04       Impact factor: 6.716

9.  Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma.

Authors:  Bao-Min Shi; Wen Lu; Kun Ji; Yu-Feng Wang; Shuai Xiao; Xiu-Yan Wang
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

10.  Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.

Authors:  Keiichi Koshizuka; Nijiro Nohata; Toyoyuki Hanazawa; Naoko Kikkawa; Takayuki Arai; Atsushi Okato; Ichiro Fukumoto; Koji Katada; Yoshitaka Okamoto; Naohiko Seki
Journal:  Oncotarget       Date:  2017-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.